A systematic evidence map of chronic inflammation and immunosuppression related to per- and polyfluoroalkyl substance (PFAS) exposure

[1]  Andrew A. Rooney,et al.  Consensus on the Key Characteristics of Immunotoxic Agents as a Basis for Hazard Identification , 2022, Environmental health perspectives.

[2]  O. Soehnlein,et al.  Neutrophils in chronic inflammatory diseases , 2022, Cellular & Molecular Immunology.

[3]  S. Sathyanarayana,et al.  Per- and Polyfluoroalkyl Substances (PFAS) in Breast Milk: Concerning Trends for Current-Use PFAS. , 2021, Environmental science & technology.

[4]  J. DeWitt,et al.  Immunotoxicity of Per- and Polyfluoroalkyl Substances: Insights into Short-Chain PFAS Exposure , 2021, Toxics.

[5]  David Q. Andrews,et al.  Investigating Molecular Mechanisms of Immunotoxicity and the Utility of ToxCast for Immunotoxicity Screening of Chemicals Added to Food , 2021, International journal of environmental research and public health.

[6]  W. Goodson,et al.  Using the Key Characteristics of Carcinogens to Develop Research on Chemical Mixtures and Cancer , 2021, Environmental health perspectives.

[7]  K. Steenland,et al.  PFAS and cancer, a scoping review of the epidemiologic evidence. , 2020, Environmental research.

[8]  D. Barr,et al.  Serum Per- and Polyfluoroalkyl Substance (PFAS) Concentrations and Predictors of Exposure among Pregnant African American Women in the Atlanta Area, Georgia. , 2020, Environmental research.

[9]  H. Eun,et al.  Per- and Polyfluoroalkyl Substances in the Air Particles of Asia: Levels, Seasonality, and Size-Dependent Distribution. , 2020, Environmental science & technology.

[10]  Chunxia Xiao,et al.  Exposure to Perfluorooctanoic Acid Induces Cognitive Deficits via Altering Gut Microbiota Composition, Impairing Intestinal Barrier Integrity, and Causing Inflammation in Gut and Brain. , 2020, Journal of agricultural and food chemistry.

[11]  A. Gu,et al.  Early-life perfluorooctanoic acid exposure induces obesity in male offspring and the intervention role of chlorogenic acid. , 2020, Environmental pollution.

[12]  P. Grandjean,et al.  Severity of COVID-19 at elevated exposure to perfluorinated alkylates , 2020, medRxiv.

[13]  Shimin Zheng,et al.  Association between per and polyfluoroalkyl substances and markers of inflammation and oxidative stress. , 2020, Environmental research.

[14]  Luoping Zhang,et al.  Benzene-associated immunosuppression and chronic inflammation in humans: a systematic review , 2020, Occupational and Environmental Medicine.

[15]  A. Gu,et al.  Autophagy mediates perfluorooctanoic acid-induced lipid metabolism disorder and NLRP3 inflammasome activation in hepatocytes. , 2020, Environmental pollution.

[16]  E. Mayo-Wilson,et al.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2020, BMJ.

[17]  Jinghua Wang,et al.  Temporal Trends in Prenatal Exposure (1998-2018) to Emerging and Legacy Per- and Polyfluoroalkyl Substances (PFASs) in Cord Plasma from Beijing Cord Blood Bank, China. , 2020, Environmental science & technology.

[18]  D. Wiley,et al.  Legacy and Novel Per- and Polyfluoroalkyl Substances (PFAS) in Juvenile Seabirds from the US Atlantic Coast. , 2020, Environmental science & technology.

[19]  Alison M Pecquet,et al.  Exposure to perfluorooctanoic acid (PFOA) decreases neutrophil migration response to injury in zebrafish embryos , 2020, BMC research notes.

[20]  R. Ge,et al.  Effects of gestational exposure to perfluorooctane sulfonate on the lung development of offspring rats. , 2020, Environmental pollution.

[21]  R. Fry,et al.  Perfluoroalkyl Substances (PFAS) and Their Effects on the Placenta, Pregnancy, and Child Development: a Potential Mechanistic Role for Placental Peroxisome Proliferator–Activated Receptors (PPARs) , 2020, Current Environmental Health Reports.

[22]  R. Kishi,et al.  Effect of prenatal exposure to per- and polyfluoroalkyl substances on childhood allergies and common infectious diseases in children up to age 7 years: The Hokkaido study on environment and children's health. , 2020, Environment international.

[23]  J. Li,et al.  [Effects of PFOS on inflammatory factors in human placental trophoblast cells]. , 2020, Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases.

[24]  Wei Chen,et al.  Intestinal environmental disorders associate with the tissue damages induced by perfluorooctane sulfonate exposure. , 2020, Ecotoxicology and environmental safety.

[25]  Linbao Zhang,et al.  Transcriptome analysis of acute exposure of the Manila clam, Ruditapes philippinarum to perfluorooctane sulfonate (PFOS). , 2020, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP.

[26]  David Q. Andrews,et al.  Application of the Key Characteristics of Carcinogens to Per and Polyfluoroalkyl Substances , 2020, International journal of environmental research and public health.

[27]  Hangjun Zhang,et al.  Mechanism of immunosuppression in zebrafish (Danio rerio) spleen induced by environmentally relevant concentrations of perfluorooctanoic acid. , 2020, Chemosphere.

[28]  M. Lag,et al.  Per- and polyfluoroalkyl substances (PFASs) modify lung surfactant function and pro-inflammatory responses in human bronchial epithelial cells. , 2020, Toxicology in vitro : an international journal published in association with BIBRA.

[29]  S. Anderson,et al.  Immunotoxicity and allergenic potential induced by topical application of perfluorooctanoic acid (PFOA) in a murine model. , 2020, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[30]  Q. Gao,et al.  Green tea polyphenols and epigallocatechin-3-gallate protect against perfluorodecanoic acid induced liver damage and inflammation in mice by inhibiting NLRP3 inflammasome activation. , 2020, Food research international.

[31]  Alejandro Lucia,et al.  Chronic inflammation in the etiology of disease across the life span , 2019, Nature Medicine.

[32]  Laura N. Vandenberg,et al.  Consensus on the key characteristics of endocrine-disrupting chemicals as a basis for hazard identification , 2019, Nature Reviews Endocrinology.

[33]  Weihsueh A. Chiu,et al.  The IARC Monographs: Updated procedures for modern and transparent evidence synthesis in cancer hazard identification , 2019, Journal of the National Cancer Institute.

[34]  Kuo-I Lin,et al.  Regulatory mechanisms of B cell responses and the implication in B cell-related diseases , 2019, Journal of Biomedical Science.

[35]  Yongju Luo,et al.  The PFOS disturbed immunomodulatory functions via nuclear Factor-κB signaling in liver of zebrafish (Danio rerio). , 2019, Fish & shellfish immunology.

[36]  K. Korach,et al.  Proposed Key Characteristics of Female Reproductive Toxicants as an Approach for Organizing and Evaluating Mechanistic Data in Hazard Assessment , 2019, Environmental health perspectives.

[37]  M. Casas,et al.  Prenatal exposure to perfluoroalkyl substances, immune-related outcomes, and lung function in children from a Spanish birth cohort study. , 2019, International journal of hygiene and environmental health.

[38]  Paul Whaley,et al.  Systematic evidence maps as a novel tool to support evidence-based decision-making in chemicals policy and risk management , 2019, Environment international.

[39]  Erin E. Yost,et al.  Proposed Key Characteristics of Male Reproductive Toxicants as an Approach for Organizing and Evaluating Mechanistic Evidence in Human Health Hazard Assessments , 2019, Environmental health perspectives.

[40]  J. Barnett,et al.  Environmental perfluoroalkyl acid exposures are associated with liver disease characterized by apoptosis and altered serum adipocytokines. , 2019, Environmental pollution.

[41]  N. Duale,et al.  Contaminants in Atlantic walruses in Svalbard Part 2: Relationships with endocrine and immune systems. , 2019, Environmental pollution.

[42]  Q. Ma,et al.  NLRP3 inflammasomes in macrophages drive colorectal cancer metastasis to the liver. , 2019, Cancer letters.

[43]  M. Longnecker,et al.  Maternal levels of perfluoroalkyl substances (PFASs) during pregnancy and childhood allergy and asthma related outcomes and infections in the Norwegian Mother and Child (MoBa) cohort. , 2019, Environment international.

[44]  Vanessa Y De La Rosa,et al.  Guideline levels for PFOA and PFOS in drinking water: the role of scientific uncertainty, risk assessment decisions, and social factors , 2019, Journal of Exposure Science & Environmental Epidemiology.

[45]  Linda Rieswijk,et al.  Key Characteristics Approach to Carcinogenic Hazard Identification. , 2018, Chemical research in toxicology.

[46]  L. L. Mugivhisa,et al.  Per- and polyfluoroalkyl substances in human breast milk and current analytical methods , 2018, Environmental Science and Pollution Research.

[47]  Jie Wei,et al.  Naringin protects against perfluorooctane sulfonate‐induced liver injury by modulating NRF2 and NF‐&kgr;B in mice , 2018, International immunopharmacology.

[48]  Zhinan Ma,et al.  Perfluorooctanoic acid stimulates ovarian cancer cell migration, invasion via ERK/NF-κB/MMP-2/-9 pathway. , 2018, Toxicology letters.

[49]  J. Pourahmad,et al.  Perfluorooctanesulfonate (PFOS) Induces Apoptosis Signaling and Proteolysis in Human Lymphocytes through ROS Mediated Mitochondrial Dysfunction and Lysosomal Membrane Labialization , 2018, Iranian journal of pharmaceutical research : IJPR.

[50]  Kiyoung Choi,et al.  Benzene , 2018, ACM Trans. Archit. Code Optim..

[51]  Ivan Rusyn,et al.  Application of the key characteristics of carcinogens in cancer hazard identification , 2018, Carcinogenesis.

[52]  G. Kissling,et al.  Immunotoxic and hepatotoxic effects of perfluoro-n-decanoic acid (PFDA) on female Harlan Sprague–Dawley rats and B6C3F1/N mice when administered by oral gavage for 28 days , 2018, Journal of immunotoxicology.

[53]  Y. Lee,et al.  Perfluoroalkyl substance exposure and urine CC16 levels among asthmatics: A case–control study of children , 2017, Environmental research.

[54]  F. Kühnel,et al.  CD4 and CD8 T lymphocyte interplay in controlling tumor growth , 2017, Cellular and Molecular Life Sciences.

[55]  Q. Shi,et al.  Inflammation and the chemical carcinogen benzo[a]pyrene: Partners in crime. , 2017, Mutation research.

[56]  J. Mecsas,et al.  Neutrophils to the ROScue: Mechanisms of NADPH Oxidase Activation and Bacterial Resistance , 2017, Front. Cell. Infect. Microbiol..

[57]  Haojun Fan,et al.  Intratracheal Instillation of Perfluorohexane Modulates the Pulmonary Immune Microenvironment by Attenuating Early Inflammatory Factors in Patients With Smoke Inhalation Injury: A Randomized Controlled Clinical Trial , 2017, Journal of burn care & research : official publication of the American Burn Association.

[58]  G. Miller,et al.  NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma , 2017, The Journal of experimental medicine.

[59]  Byung‐Heon Lee,et al.  Association between perfluorooctanoic acid exposure and degranulation of mast cells in allergic inflammation , 2017, Journal of applied toxicology : JAT.

[60]  R. Dietz,et al.  Immunomodulatory effects of exposure to polychlorinated biphenyls and perfluoroalkyl acids in East Greenland ringed seals (Pusa hispida). , 2016, Environmental research.

[61]  Zihai Li,et al.  Targeting inflammasome/IL-1 pathways for cancer immunotherapy , 2016, Scientific Reports.

[62]  T. K. Jensen,et al.  Association between prenatal exposure to perfluorinated compounds and symptoms of infections at age 1-4years among 359 children in the Odense Child Cohort. , 2016, Environment international.

[63]  X. Qin,et al.  Testosterone-Mediated Endocrine Function and TH1/TH2 Cytokine Balance after Prenatal Exposure to Perfluorooctane Sulfonate: By Sex Status , 2016, International journal of molecular sciences.

[64]  T. Mitsui,et al.  The Association of Prenatal Exposure to Perfluorinated Chemicals with Glucocorticoid and Androgenic Hormones in Cord Blood Samples: The Hokkaido Study , 2016, Environmental health perspectives.

[65]  Neal R. Haddaway,et al.  A methodology for systematic mapping in environmental sciences , 2016, Environmental Evidence.

[66]  N. Masood,et al.  Natural killer cells enhance the immune surveillance of cancer , 2016 .

[67]  R. Luebke,et al.  Suppression of antigen-specific antibody responses in mice exposed to perfluorooctanoic acid: Role of PPARα and T- and B-cell targeting , 2016, Journal of immunotoxicology.

[68]  Hui-ming Chen,et al.  Investigation of the Effects of Perfluorooctanoic Acid (PFOA) and Perfluorooctane Sulfonate (PFOS) on Apoptosis and Cell Cycle in a Zebrafish (Danio rerio) Liver Cell Line , 2015, International journal of environmental research and public health.

[69]  Ivan Rusyn,et al.  Key Characteristics of Carcinogens as a Basis for Organizing Data on Mechanisms of Carcinogenesis , 2015, Environmental health perspectives.

[70]  M. Wolff,et al.  Perfluoroalkyl and Polyfluoroalkyl Substances and Indicators of Immune Function in Children Aged 12 – 19 years: NHANES , 2015, Pediatric Research.

[71]  J. Depierre,et al.  Complement activation is involved in the hepatic injury caused by high-dose exposure of mice to perfluorooctanoic acid. , 2015, Chemosphere.

[72]  I. Meza,et al.  A novel β-catenin signaling pathway activated by IL-1β leads to the onset of epithelial-mesenchymal transition in breast cancer cells. , 2014, Cancer letters.

[73]  Ying Ding,et al.  The role of interleukin family in perfluorooctanoic acid (PFOA)-induced immunotoxicity. , 2014, Journal of hazardous materials.

[74]  H. Pass,et al.  Asbestos‐Induced Chronic Inflammation and Cancer , 2014 .

[75]  J. Egido,et al.  Activation of Toll-Like Receptors and Inflammasome Complexes in the Diabetic Cardiomyopathy-Associated Inflammation , 2014, International journal of endocrinology.

[76]  Jie Wei,et al.  Involvement of Oxidative Stress and Inflammation in Liver Injury Caused by Perfluorooctanoic Acid Exposure in Mice , 2014, BioMed research international.

[77]  L. S. Haug,et al.  Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood , 2013, Journal of immunotoxicology.

[78]  V. Segura,et al.  Silica-induced chronic inflammation promotes lung carcinogenesis in the context of an immunosuppressive microenvironment. , 2013, Neoplasia.

[79]  P. Kubes,et al.  Neutrophil recruitment and function in health and inflammation , 2013, Nature Reviews Immunology.

[80]  Yi-he Jin,et al.  Mechanism of perfluorooctanesulfonate (PFOS)-induced apoptosis in the immunocyte , 2013, Journal of immunotoxicology.

[81]  W. Liu,et al.  Serum Polyfluoroalkyl Concentrations, Asthma Outcomes, and Immunological Markers in a Case–Control Study of Taiwanese Children , 2013, Environmental health perspectives.

[82]  J. Tschopp,et al.  NLRP3 suppresses NK cell-mediated responses to carcinogen-induced tumors and metastases. , 2012, Cancer research.

[83]  J. Tschopp,et al.  NLRP3 promotes inflammation‐induced skin cancer but is dispensable for asbestos‐induced mesothelioma , 2012, Immunology and cell biology.

[84]  E. Alnemri,et al.  Non-transcriptional Priming and Deubiquitination Regulate NLRP3 Inflammasome Activation* , 2012, The Journal of Biological Chemistry.

[85]  Haichao Wang,et al.  In vitro and in vivo studies of the toxic effects of perfluorononanoic acid on rat hepatocytes and Kupffer cells. , 2012, Environmental toxicology and pharmacology.

[86]  J. Depierre,et al.  High-dose dietary exposure of mice to perfluorooctanoate or perfluorooctane sulfonate exerts toxic effects on myeloid and B-lymphoid cells in the bone marrow and these effects are partially dependent on reduced food consumption. , 2012, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[87]  Wei Zhang,et al.  Kupffer cells suppress perfluorononanoic acid-induced hepatic peroxisome proliferator-activated receptor α expression by releasing cytokines , 2012, Archives of Toxicology.

[88]  Yi-he Jin,et al.  Subchronic effects of perfluorooctanesulfonate exposure on inflammation in adult male C57BL/6 mice , 2012, Environmental toxicology.

[89]  Sang-Hyun Kim,et al.  Perfluorooctanoic acid induces mast cell-mediated allergic inflammation by the release of histamine and inflammatory mediators. , 2012, Toxicology letters.

[90]  Marina Marinovich,et al.  In vitro characterization of the immunotoxic potential of several perfluorinated compounds (PFCs). , 2012, Toxicology and applied pharmacology.

[91]  G. Jiang,et al.  Modulation of dietary fat on the toxicological effects in thymus and spleen in BALB/c mice exposed to perfluorooctane sulfonate. , 2011, Toxicology letters.

[92]  Yi-he Jin,et al.  Sub-chronic effect of perfluorooctanesulfonate (PFOS) on the balance of type 1 and type 2 cytokine in adult C57BL6 mice , 2011, Archives of Toxicology.

[93]  J. Depierre,et al.  Dietary exposure to perfluorooctanoate or perfluorooctane sulfonate induces hypertrophy in centrilobular hepatocytes and alters the hepatic immune status in mice. , 2010, International immunopharmacology.

[94]  Jae-ho Yang.  Perfluorooctanoic acid induces peroxisomal fatty acid oxidation and cytokine expression in the liver of male Japanese medaka (Oryzias latipes). , 2010, Chemosphere.

[95]  Jiayin Dai,et al.  Perfluorononanoic acid-induced apoptosis in rat spleen involves oxidative stress and the activation of caspase-independent death pathway. , 2010, Toxicology.

[96]  Sang-Hyun Kim,et al.  Perfluorooctanoic acid alters T lymphocyte phenotypes and cytokine expression in mice , 2009, Environmental toxicology.

[97]  J. Depierre,et al.  High-dose, short-term exposure of mice to perfluorooctanesulfonate (PFOS) or perfluorooctanoate (PFOA) affects the number of circulating neutrophils differently, but enhances the inflammatory responses of macrophages to lipopolysaccharide (LPS) in a similar fashion. , 2009, Toxicology.

[98]  Yi-he Jin,et al.  Immunotoxic changes associated with a 7-day oral exposure to perfluorooctanesulfonate (PFOS) in adult male C57BL/6 mice , 2009, Archives of Toxicology.

[99]  J. Depierre,et al.  The atrophy and changes in the cellular compositions of the thymus and spleen observed in mice subjected to short-term exposure to perfluorooctanesulfonate are high-dose phenomena mediated in part by peroxisome proliferator-activated receptor-alpha (PPARalpha). , 2009, Toxicology.

[100]  R. Luebke,et al.  Suppression of humoral immunity by perfluorooctanoic acid is independent of elevated serum corticosterone concentration in mice. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[101]  Jiayin Dai,et al.  Alterations of cytokines and MAPK signaling pathways are related to the immunotoxic effect of perfluorononanoic acid. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[102]  Yong Zhao,et al.  Immunotoxic effects of perfluorononanoic acid on BALB/c mice. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[103]  J. M. Keller,et al.  Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[104]  D. Keil,et al.  Gestational exposure to perfluorooctane sulfonate suppresses immune function in B6C3F1 mice. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[105]  Xu Li,et al.  [Effects of peroxisome proliferators PFOA on immune system of mice]. , 2006, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology.

[106]  Kazuo Kobayashi,et al.  Macrophages in inflammation. , 2005, Current drug targets. Inflammation and allergy.

[107]  R. Luebke,et al.  Suppression of Immune Function and Susceptibility to Infections in Humans: Association of Immune Function with Clinical Disease , 2004, Journal of immunotoxicology.

[108]  Qiang Yang,et al.  Further evidence for the involvement of inhibition of cell proliferation and development in thymic and splenic atrophy induced by the peroxisome proliferator perfluoroctanoic acid in mice. , 2001, Biochemical pharmacology.

[109]  PFAS POLLUTION ACROSS THE MIDDLE EAST AND ASIA , 2019 .

[110]  B. Jenkins,et al.  Inflammasome Adaptor ASC Suppresses Apoptosis of Gastric Cancer Cells by an IL18-Mediated Inflammation-Independent Mechanism. , 2018, Cancer research.

[111]  Limin Liu,et al.  Perfluorooctane sulphonate induces oxidative hepatic damage via mitochondria-dependent and NF-κB/TNF-α-mediated pathway. , 2018, Chemosphere.

[112]  F. Liu,et al.  Grape seed proanthocyanidin extract protects against perfluorooctanoic acid-induced hepatotoxicity by attenuating inflammatory response, oxidative stress and apoptosis in mice. , 2016, Toxicology research.

[113]  Xingguo Cheng,et al.  Acute Immunotoxic Effects of Perfluorononanoic Acid (PFNA) in C57BL/6 Mice. , 2013, Clinical & experimental pharmacology.

[114]  Y. Saijo,et al.  Prenatal exposure to perfluorinated chemicals and relationship with allergies and infectious diseases in infants. , 2012, Environmental research.

[115]  Arsenic, metals, fibres, and dusts. , 2012, IARC monographs on the evaluation of carcinogenic risks to humans.

[116]  S. Anderson,et al.  Exposure to the immunosuppressant, perfluorooctanoic acid, enhances the murine IgE and airway hyperreactivity response to ovalbumin. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.